Cardiovascular catheters represent one of the highest-value segments of the catheters market, underpinning angiography, angioplasty, stenting, and electrophysiology procedures. As minimally invasive cardiac interventions expand — now accounting for roughly 75% of cardiovascular procedures in developed systems — demand for diagnostic and therapeutic catheters continues to rise .

The market is being driven by rising cardiovascular disease prevalence, growth in interventional cardiology, expansion of pulsed-field ablation platforms, and ageing populations . According to catheters market research, cardiovascular catheters represent a leading product segment, supported by high procedure volumes. Growth is driven by the shift from open surgery to catheter-based interventions.

Innovation includes dual-energy ablation catheters (radiofrequency and pulsed-field), steerable tips, and integrated mapping and sensing platforms . Abbott received CE Mark for its TactiFlex Duo catheter in January 2026 .

Challenges include cost, procedural complexity, and competition from emerging technologies.

Yet the trend is clear: cardiovascular catheters will remain a high-value segment, and the market is expected to benefit substantially.

People Also Ask

Q: Why are cardiovascular catheters a major market segment?
A: They support high-volume interventional procedures such as angioplasty, stenting, and ablation, which are increasingly preferred over open surgery .

Q: What are pulsed-field ablation catheters?
A: They are catheters that deliver pulsed electrical fields to ablate cardiac tissue, offering an alternative to radiofrequency ablation .

Tags: #CardiovascularCatheters #InterventionalCardiology #Ablation #PulsedFieldAblation #CardiacCare #MarketTrends